External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

IASLC-NACLC 2023

-
Coming soon
11:40 PM
Duration 75mins Chicago, USA
Switching to Subcutaneous (SC) Atezolizumab After Intravenous (IV) Dosing: Evaluation of Atezolizumab Pharmacokinetics (PK) Using Population PK Modeling
Stephanie N Liu, Phyllis Chan, Mathilde Marchan, Luis Herraez-Baranda, Rene Bruno, Pascal Chanu, Benjamin Wu

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 75mins Chicago, USA
Real-world treatment patterns among resected NSCLC patients treated with adjuvant atezolizumab
Jay M. Lee, Sarika Ogale, Ann Johnson, Achal Patel, Husam Albarmawi, Janet S. Lee

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 75mins Chicago, USA
Patient characteristics and treatment patterns in biomarker selected early non-small cell lung cancer
Fawzi Abu Rous, Jesse Sussell, Celina Ngiam Kochounian, Qing Zhang, Thomas Majda, Danny Sheinson, Sarika Ogale, Ilze Bara, Shirish Gadgeel,

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:30 PM
Duration 10mins Marriott
Alectinib vs Chemotherapy in Non-Asian Patients with Resected ALK+ Non-Small Cell Lung Cancer from the ALINA trial
Prof Fabrice Barlesi, Prof. Benjamin J. Solomon, Prof. Jin Seok Ahn, Prof. Rafal Dziadziuszko, Prof. Makoto Nishio, Dr. Maximilian Hochmair, Prof. Filippo de Marinis, Dr. Maria Rita Migliorino, Prof. Igor Bondarenko, Dr. Andriy Kurochkin, Prof. Hakan Harputluoglu, Dr. David Planchard, Dr Ibiayi Dagogo-Jack, Dr. Thorsten Ruf, Ms. Tingting Xu, Dr. Wei Yu, Dr. Venice Archer, Dr. Vlatka Smoljanovic, Dr. Celina Ngiam, Dr. Ilze Bara, Prof. Yi-Long Wu

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar